Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01)
2007-005057-36Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of hydroxychloroquine in human immunodeficiency virus infection (HIV), sponsored by Medical Research Council. Primary endpoint: Change in CD8 T-cell activation. Started Jan 2008; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-005057-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005057-36.